Buy side Monthly archive

Jan 30, 2019
Hermes: 2019 could be turning point for emerging markets
Today’s emerging markets are ‘better placed to weather shocks’ than in the past, according to a research note from Silvia Dall’Angelo, senior economist at Hermes Investment Management, who argues that ‘improved financial resilience, robust policies and few new tailwinds could support a brighter 2019 across emerging markets.’ This follows a ‘challenging’ backdrop to 2018, caused by global financial conditions, slowing growth in China and ‘fraught’...
Read more
Jan 29, 2019
ETF providers turn to strategic beta strategies after market turmoil
Exchange-traded fund (ETF) providers are turning to more expensive strategic beta and actively managed strategies after rapid industry growth froze last year with the end-of-year stock market turmoil. More than half (57 percent) of ETF issuers highlight that they are developing strategic beta strategies – which use rules-based strategies that are not necessarily market-weighted – compared with 41 percent of issuers that report developing active ETFs and 36 perce...
Read more
Jan 25, 2019
Five trends changing the ESG investing landscape in 2019
The field of ESG investing has undergone rapid changes in recent years. Below, we share five trends we’re seeing in the space, and what they mean for investors. Trend one: Investors are moving from purely exclusionary to integrated ESG strategies For decades, asset owners have used exclusionary strategies to keep securities that did not align with their values out of their portfolios. Increasingly, we see investors embrace ESG investing due...
Read more
Jan 25, 2019
UK biotech sector sees massive boost in 2018
The UK biotech sector was given a massive boost last year when it raised a record £2.2 bn ($2.9 bn) from investors. New figures in a report from the UK BioIndustry Association (BIA) and Informa Pharma Intelligence – ‘Confident capital: backing UK biotech’ – show the total is the best ever recorded, and almost double the £1.2 bn raised by UK-based biotech co...
Read more
Jan 25, 2019
How long-term investors deal with short-term pressures
Asset owners with a long-term time horizon are not immune to short-term pressures, according to a new publication from FCLT Global. The 30-page publication – ‘Balancing act: managing risk across multiple time horizons’ – addresses the challenge of managing multiple-horizon portfolios such as pension plans, sovereign wealth funds and endowments, by outlining why such management is important.  The report builds on the findings uncovered at ...
Read more
Jan 21, 2019
BofAML survey reveals secular stagnation outlook
Investors’ expectations for global GDP growth continue to fall, as 60 percent of those surveyed in the Bank of America Merrill Lynch (BofAML) January Fund Manager Survey think global growth will weaken over the next 12 months. This is the worst outlook on the global economy since July 2008 and below the trough seen in January 2001. This month’s survey finds the worst outlook on profits since 2008, with 52 percent of investors expecting global profits to d...
Read more
Jan 16, 2019
Hedge funds marginally outperform market
Hedge funds marginally outperformed the market last year, posting a 4.07 percent annual loss versus the S&P’s 4.38 percent fall, according to data from Chicago-based Hedge Fund Research (HFR). The last time hedge funds beat the market was during the financial crisis. The HFRI Fund Weighted Composite (FWC) Index – constructed to capture the breadth of hedge fund performance trends – fell 1.97 percent in December, topping US equities and most global a...
Read more
Jan 15, 2019
BlackRock urged to close gap between rhetoric and reality on climate action
Twelve investor and shareholder advocacy groups have written to BlackRock, calling on it to improve its climate-related shareholder resolutions and engagements. This comes in anticipation of BlackRock CEO’s yearly letter to companies reminding them of their need to address global strategic challenges and deliver long-term value for shareholders and society. The letter calls out the fund manager for its own ‘poor contribution to environmental goals’, esp...
Read more
Jan 08, 2019
Spotlight on: The view from the buy side for 2019
We hear from expert investors Chantal Brennan, research director at Davy Asset Management, and Matthieu Rolin, portfolio manager at Aviva Investors France, who outline the key trends over the past year and give us a glimpse into what 2019 holds from a buy-side perspective.  What was your main focus during 2018? Chantal Brennan: Our main focus in 2018 was on adapting to the changes brought about by ...
Read more
logo-black logo-black
Loading